Anthony Doyle - 14 Dec 2021 Form 4/A - Amendment Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Chief Financial Officer
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
14 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 Jan 2022, 15:40:59 UTC
Date Of Original Report
16 Dec 2021
Previous filing
24 Nov 2021
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $0 +75,000 +80% $0.000000 168,719 14 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date.